Target intelligence / Profile preview

Heat-labile Enterotoxin (HLT)

Target
HLT
Molecular classification
AB5 Toxin, ADP-ribosyltransferase
01

Overview

Heat-labile enterotoxins (HLTs) are potent immunomodulatory proteins produced by bacteria such as *Escherichia coli* and *Vibrio cholerae*. They are AB5-type toxins with an A subunit possessing ADP-ribosyltransferase activity and a pentameric B subunit for cell binding. HLTs, especially the heat-labile enterotoxin from *E. coli* (LT), have been extensively studied for their strong adjuvant properties in mucosal vaccines. Mutant forms like mLT or dmLT are engineered to reduce toxicity while retaining adjuvanticity.

Other names
LTE. coli Heat-labile ToxinCholera-like toxinmLT (mutant LT)dmLT [LT(R192G/L211A)]
02

Mechanism of action

HLTs act primarily by increasing intracellular cAMP via activation of adenylate cyclase after binding to ganglioside receptors on host cells. This elevation in cAMP modulates immune responses by enhancing antigen-presenting cell function, promoting B cell differentiation, and inducing Th2 responses.

03

Biological functions

Immune modulationActivation of adenylate cyclaseEnhancement of antigen-presenting cell functionPromotion of B cell differentiationInduction of Th2 responsesInduction of Th17 responses
04

Disease associations

Infectious disease (E. coli, Vibrio cholerae)Vaccine adjuvant
05

Safety considerations

Enterotoxicity (native LT)Potential adverse events at high doses or with certain whole-cell vaccines (mutant forms)

Beyond the preview

Go deeper on Heat-labile Enterotoxin (HLT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat-labile Enterotoxin (HLT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call